HEART TEST LABORATORIES INC's ticker is and the CUSIP is 42254E104. A total of 9 filers reported holding HEART TEST LABORATORIES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,653 | -71.0% | 69,607 | -38.3% | 0.01% | -67.6% |
| Q2 2023 | $102,133 | -33.9% | 112,854 | -27.9% | 0.04% | -43.9% |
| Q1 2023 | $154,594 | +13.7% | 156,630 | -3.2% | 0.07% | -14.3% |
| Q4 2022 | $135,932 | +353.1% | 161,844 | +547.4% | 0.08% | +305.3% |
| Q3 2022 | $30,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | 161,844 | $135,932 | 0.08% |
| CHAPIN DAVIS, INC. | 55,000 | $46,195 | 0.03% |
| Tradition Wealth Management, LLC | 39,993 | $34 | 0.01% |
| AE Wealth Management LLC | 154,204 | $129,516 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,995 | $6 | 0.00% |
| Renaissance Technologies | 22,900 | $19 | 0.00% |
| UBS Group AG | 1,953 | $1,641 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11 | $9 | 0.00% |